Prosecution Insights
Last updated: April 19, 2026

Delix Therapeutics Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18001191 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 Non-Final OA Dec 08, 2022
18001190 TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF HSU, GRACE CHING 1627 Non-Final OA Dec 08, 2022
17768725 ERGOLINE-LIKE COMPOUNDS FOR PROMOTING NEURAL PLASTICITY STOCKTON, LAURA LYNNE 1626 Final Rejection Apr 13, 2022

Managing Delix Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month